Solasto Corporation announced that, effective 19 October 2026, Sasai Hidetaka (笹井英孝) became representative director, president and Solasto Group CEO, while former CEO Noda Toru (野田亨) became chairman of the board. The company is moving to a new management structure following its privatization.
Solasto Corporation announced on 19 October 2026 that a new representative director and president and Solasto Group CEO would take office. Former president Noda Akira (野田 亨) is scheduled to become chairman of the board and will promote the company’s growth strategy under the new management structure.
As background to the change, the company said it completed a take-private transaction in August 2026 and will bring in Sasai Hidetaka (笹井 英孝), who has extensive experience in management and organisational transformation, to ensure that its future business strategy can be executed reliably and with speed.
The incoming leader, Sasai Hidetaka (笹井 英孝), graduated from the University of Tokyo’s Faculty of Law and completed an MBA at Columbia Business School. After working for major financial institutions and foreign-affiliated consulting firms, he spent many years managing businesses in the healthcare and welfare sectors. Most recently, he served as CEO of Tryt Group and reportedly led the company’s listing on the TSE Growth Market.
Solasto Group has approximately 33,000 employees and operates healthcare businesses, including outsourced medical administration, as well as nursing care and childcare businesses. Details of its business policies and specific strategies under the new management structure will be disclosed in due course.